ACC/AHA guideline update for the management of p... [Circulation. 2002] - PubMed

Save items

loading

Related citations in PubMed

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). [J Am Coll Cardiol. 2002]
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).
Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, et al. J Am Coll Cardiol. 2002 Oct 2; 40(7):1366-74.
Review Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. [JAMA. 2000]
Review Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Bhatt DL, Topol EJ. JAMA. 2000 Sep 27; 284(12):1549-58.
A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials. [Circ Cardiovasc Interv. 2009]
A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.
Gurm HS, Tamhane U, Meier P, Grossman PM, Chetcuti S, Bates ER. Circ Cardiovasc Interv. 2009 Jun; 2(3):230-6. Epub 2009 Apr 21.
Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE). [Am J Cardiol. 2007]
Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE).
Tricoci P, Peterson ED, Chen AY, Newby LK, Harrington RA, Greenbaum AB, Cannon CP, Gibson CM, Hoekstra JW, Pollack CV Jr, et al. Am J Cardiol. 2007 May 15; 99(10):1389-93. Epub 2007 Mar 26.
Review 2002 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. [Ann Emerg Med. 2003]
Review 2002 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice.
Pollack CV Jr, Roe MT, Peterson ED. Ann Emerg Med. 2003 Mar; 41(3):355-69.

See reviews... See all...

Cited by 69 PubMed Central articles

Financial stress and outcomes after acute myocardial infarction. [PLoS One. 2012]
Financial stress and outcomes after acute myocardial infarction.
Shah SJ, Krumholz HM, Reid KJ, Rathore SS, Mandawat A, Spertus JA, Ross JS. PLoS One. 2012; 7(10):e47420. Epub 2012 Oct 24.
Serum 25(OH)D is a 2-year predictor of all-cause mortality, cardiac death and sudden cardiac death in chest pain patients from Northern Argentina. [PLoS One. 2012]
Serum 25(OH)D is a 2-year predictor of all-cause mortality, cardiac death and sudden cardiac death in chest pain patients from Northern Argentina.
Naesgaard PA, León De La Fuente RA, Nilsen ST, Woie L, Aarsland T, Brede C, Staines H, Nilsen DW. PLoS One. 2012; 7(9):e43228. Epub 2012 Sep 6.
Review Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care. [Methodist Debakey Cardiovasc J...]
Review Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care.
Christodoulides N, Pierre FN, Sanchez X, Li L, Hocquard K, Patton A, Muldoon R, Miller CS, Ebersole JL, Redding S, et al. Methodist Debakey Cardiovasc J. 2012 Jan; 8(1):6-12.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

ACC/AHA guideline update for the management of patients with unstable angina and...
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
Circulation. 2002 Oct 1 ;106(14):1893-900.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Education

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 69 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information